: An Emerging Infectious Threat in Transfusion Medicine

article has not abstract

Vyšlo v časopise: : An Emerging Infectious Threat in Transfusion Medicine. PLoS Pathog 9(7): e32767. doi:10.1371/journal.ppat.1003387
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003387

Souhrn

article has not abstract

Zdroje

1. LantosPM, KrausePJ (2002) Babesiosis: similar to malaria but different. Pediatr Ann 31: 192–197.

2. LeibyDA (2011) Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 24: 14–28.

3. ConradPA, KjemtrupAM, CarrenoRA, ThomfordJ, WainwrightK, et al. (2006) Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 36: 779–789.

4. HerwaldtB, PersingDH, PrecigoutEA, GoffWL, MathiesenDA, et al. (1996) A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 124: 643–650.

5. GigandetL, StaufferE, DouetV, RaisO, MoretJ, et al. (2011) Prevalence of three zoonotic Babesia species in Ixodes ricinus (Linne, 1758) nymphs in a suburban forest in Switzerland. Vector Borne Zoonotic Dis 11: 363–366.

6. GrayJS (2006) Identity of the causal agents of human babesiosis in Europe. Int J Med Microbiol 296(Suppl 40): 131–136.

7. KjemtrupAM, ConradPA (2000) Human babesiosis: an emerging tick-borne disease. Int J Parasitol 30: 1323–1337.

8. RuebushTK2nd, JuranekDD, ChisholmES, SnowPC, HealyGR, et al. (1977) Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med 297: 825–827.

9. GubernotDM, NakhasiHL, MiedPA, AsherDM, EpsteinJS, et al. (2009) Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion 49: 2759–2771.

10. LeibyDA (2011) Transfusion-associated babesiosis: shouldn't we be ticked off? Ann Intern Med 155: 556–557.

11. KrausePJ, SpielmanA, TelfordSR3rd, SikandVK, McKayK, et al. (1998) Persistent parasitemia after acute babesiosis. N Engl J Med 339: 160–165.

12. WormserGP, PrasadA, NeuhausE, JoshiS, NowakowskiJ, et al. (2010) Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis 50: 381–386.

13. WittnerM, RowinKS, TanowitzHB, HobbsJF, SaltzmanS, et al. (1982) Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96: 601–604.

14. KrausePJ, LeporeT, SikandVK, GadbawJJr, BurkeG, et al. (2000) Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 343: 1454–1458.

15. TonnettiL, EderAF, DyB, KennedyJ, PisciottoP, et al. (2009) Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 49: 2557–2563.

16. GerberMA, ShapiroED, KrausePJ, CableRG, BadonSJ, et al. (1994) The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 170: 231–234.

17. EberhardML, WalkerEM, SteurerFJ (1995) Survival and infectivity of Babesia in blood maintained at 25 C and 2–4 C. J Parasitol 81: 790–792.

18. JohnsonST, Van TassellER, TonnettiL, CableRG, BerardiVP, et al. (2013) Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms. Transfusion E-pub ahead of print. doi:10.1111/trf.12125

19. YoungC, ChawlaA, BerardiV, PadburyJ, SkowronG, et al. (2012) Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion 52: 1523–1529.

20. CancelasJA, DumontLJ, RuggN, SzczepiorkowskiZM, HerschelL, et al. (2011) Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. Transfusion 51: 2367–2376.

21. ReddyHL, DoaneSK, KeilSD, MarschnerS, GoodrichRP (2013) Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion 53(Suppl 1): 131S–136S.

22. TonnettiL, ThorpAM, ReddyHL, KeilSD, GoodrichRP, et al. (2012) Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion 53: 860–867.